Key result
PRP-loaded hydrogel injection improves post-MI LVEF by ~17 percentage points in rat models.
Why the study?
Clinical translation of platelet-rich plasma for myocardial infarction has been limited by the short half-life and rapid inactivation of its growth factors.
Does PRP-PLL/PEG hydrogel improve cardiac function and ameliorate ventricular remodeling in a rat model of myocardial infarction?
Does PRP-PLL/PEG hydrogel improve cardiac function and ameliorate ventricular remodeling in a rat model of myocardial infarction?
Absolute Event Rate: 66.57% vs 49.3%
p-value: p=<0.05
A novel pH-responsive PRP-loaded PEG-NHS/PLL hydrogel promotes neovascularization, suppresses fibrosis and inflammation, and improves cardiac function in a rat model of myocardial infarction.
Supports further preclinical testing of pH-responsive PRP hydrogels; leaves open clinical translation pending larger studies.
The incidence and mortality rates of myocardial infarction (MI) worldwide have exhibited a sustained upward trend. Platelet-rich plasma (PRP) is enriched with a diverse repertoire of growth factors that promote cellular proliferation, revascularization and tissue repair, thereby emerging as a promising therapeutic modality for improving MI prognosis. However, the short half-life and inherent tendency of these growth factors to undergo rapid inactivation have hitherto constrained the clinical translation of PRP. Medical hydrogels are regarded as promising platforms for cardiac tissue engineering and localized drug delivery in the context of MI. Herein, we developed a polyethylene glycol-succinimidyl ester/poly-L-lysine (PEG-NHS/PLL) hydrogel engineered for the integration of PRP. The hydrogel strength could be tailored by adjusting the PLL and PEG-NHS ratio to match individualized post-MI treatment needs, while the optimal gelation time (5-10 s) facilitated clinical translation. Electrostatic interactions between the cationic moieties of PLL and PRP-derived bioactive factors contribute to their sustained and controlled release. Moreover,the hydrogel exhibited a faster release rate of PRP under acidic conditions and demonstrated excellent pH-responsive sustained-release properties. The PEG-NHS/PLL hydrogel facilitated the restoration of cardiac function after MI by suppressing fibrotic remodeling, reducing cardiomyocyte apoptosis, scavenges reactive oxygen (ROS) species and promoting neovascularization.
No takes yet. Share an insight, caveat, or question.
Liu et al. (2025) studied Myocardial Infarction. PRP-loaded PLL/PEG hydrogel vs. PBS (MI control), PLL/PEG hydrogel, sterile PRP, or alginate gel was evaluated on Left-ventricular ejection fraction (LVEF) at 14 days (p=<0.05). Intracardiac injection of PRP-loaded PLL/PEG hydrogel improved left-ventricular ejection fraction to 66.57% vs 49.30% in controls at 14 days post-myocardial infarction in rats.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: